DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Eric Linsley will co-chair the CED’s 25th Annual Venture Conference in Durham, NC
News | 04. 16. 2008
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.